Mon, 20 May 2013
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio)
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes a new staging system.
Direct download: GRACEcast-152_Lung-Audio_Kratz_Pt3_Evidence_for_Biology_Based_Staging.mp3
Category:Lung-Cancer-Audio -- posted at: 3:50pm PDT